Furthermore, TF activation has been reported in the presence of SARS-CoV-2, and there is evidence that TF expression can be disrupted by inhibiting the complement component C3, suggesting that the complement axis plays a critical role in COVID-19-induced inflammation (109). This evidence concerns the gene C3 and COVID-19.